Stay updated on Pembrolizumab Combo in Metastatic Melanoma: Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Metastatic Melanoma: Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Metastatic Melanoma: Clinical Trial page
- Check7 days agoChange DetectedThe study record now lists the investigator Wilson Miller and Jewish General Hospital as collaborators and adds new navigation elements and section labels (How to Read a Study Record, Common Questions, How to Join a Study) along with an updated Intervention/Treatment heading. The page revision has been updated to v3.6.0, and previously shown items such as 'Last known status was:' and 'Verified' were removed along with the older 'Intervention / Treatment' label and revision tag.SummaryDifference2%

- Check14 days agoChange DetectedRevision: v3.5.5 replaces the previous Revision: v3.5.4. This reflects a page version update without altering the study details or user workflow.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check36 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4, indicating a software/backend update. No visible study details or eligibility criteria appear to be changed.SummaryDifference0.1%

- Check50 days agoChange DetectedA new revision tag v3.5.3 was added and the previous v3.5.2 tag removed, signaling an updated version of the study record.SummaryDifference0.1%

- Check64 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. This appears to be a backend/software version update and does not modify the study details or page content.SummaryDifference0.1%

- Check86 days agoChange DetectedRevision label updated to v3.5.0; the previous Revision: v3.4.3 label was removed.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Combo in Metastatic Melanoma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Metastatic Melanoma: Clinical Trial page.